EIF2AK3 and lung carcinoma: As is shown in Figure 9B, the lncCDH5-3:3 overexpression causes different effects in the three lung cancer cell lines: in A549 cells, it increases the levels of Akt, pAkt, ERK, and pERK; in H1975 cells, it increases the levels of pAkt, and pERK; and in H1703, it increases the levels of ERK and pERK.